July 12, 2024
TOPLINE: Lowering the dose of edoxaban to 30 mg in patients 80 years of age and older with atrial fibrillation (AF) reduces major bleeding events without […]
July 12, 2024
VIENNA — Glucocorticoid discontinuation is possible without increasing flare risk, if tapered slowly and carefully, in patients with systemic lupus erythematosus (SLE) in stable remission. In […]
July 12, 2024
As bird flu spreads among dairy cattle in the US, veterinarians and researchers have taken note of Finland’s move to vaccinate farmworkers at risk of infection. […]
July 11, 2024
Listen Welcome to the FDA Drug Safety Podcast for health care professionals from the Division of Drug Information. On June 16, 2021, FDA warned that symptoms […]
July 11, 2024
A U.S. Food and Drug Administration (FDA) review of study findings showed a potential increased risk of heart rhythm problems, called arrhythmias, in patients with heart […]
July 11, 2024
[Update 7-11-2024] FDA is aware that additional Schwinnng products are being sold in packaging labeled as “On Command” (see image below). These products are being sold […]
July 11, 2024
On This Page Date: July 11, 2024 Visit CDER Small Business and Industry Assistance Page ABOUT THIS EVENT (Hosted by CDER SBIA) FDA is announcing a […]
July 11, 2024
Every doctor encounters patients who complain of symptoms without identifiable physical causes. According to a recent review in The Lancet, one third of all symptoms lack […]
July 11, 2024
The Brief Summary is a quarterly bulletin intended for all Office of Prescription Drug Promotion (OPDP) stakeholders. The Brief Summary provides news and updates related to […]